Source: Doan LV, Hung AM, Olfson M, Williams NT, Rudolph KE. Initial Treatment for Acute Low Back Pain and Risk of Opioid Use Disorder and Overdose. JAMA Netw Open. 2026;9(10):e2639420. doi:10.1001/jamanetworkopen.2026.39420 Key Points Question What is the incidence of opioid use disorder (OUD) or...

Source: Bhatraju EP, Zinsli KA, Kennedy DN, et al. Patient Navigation Plus mHealth Incentives for Linkage to OUD Care for Adults Who Also Use Methamphetamines: A Pilot Randomized Clinical Trial. JAMA Netw Open. 2026;9(10):e2638542. doi:10.1001/jamanetworkopen.2026.38542 Key Points Question Is an...

Source: Kleinman RA, Larney S, Sule NO, Ma C, Hauck TS, Kurdyak P. Methadone vs Buprenorphine-Naloxone in Opioid Overdose Survivors. JAMA Netw Open. 2026;9(8):e2629313. doi:10.1001/jamanetworkopen.2026.29313 Key Points Question Among individuals with a past-year opioid overdose starting opioid...

Source: Hayes, C. J., Raciborski, R. A., Acharya, M., Noor, N. B., Nunes, E. V., & Winhusen, T. J. (2026). Evaluating the optimal duration of medication treatment for opioid use disorder. Addiction, 121(4), 922-933. https://doi.org/10.1111/add.70211 Abstract Background and aims Clinicians have...

Source: Allen, B., Basaraba, C., Chambers, L. C., Behrends, C. N., Marshall, B. D., & Cerdá, M. (2026). Overdose prevention centers and neighborhood commercial activity in New York City. JAMA Network Open, 9(2), e2559863. Key Points Question Are overdose prevention centers (OPCs) associated with...

Source: Saloner, B., O’Rourke, A., Ruelas-Vargas, K., Song, M., Ramsey, K. S., & Bandara, S. (2026). Driving Distance From US Jails to Opioid Treatment Programs. JAMA Network Open, 9(3), e264044-e264044. Discussion In this study, 51.5% of US jails were located more than a 30-minute drive from an OTP...

Source: Engeriser, J.L., Hutch, T., Smith, C.L. et al. Buprenorphine initiation from fentanyl using low-dose intramuscular ketamine: a pilot study. Addict Sci Clin Pract 21, 23 (2026). https://doi.org/10.1186/s13722-026-00649-3 Abstract Background Buprenorphine is an effective medication for...

Source: DeLisle, D. E., Mark, T. L., Katz, C., Dowd, W. N., Barch, D., & Kluckman, M. (2026). Opioid Treatment Programs’ Medicaid Patient Retention Rates. JAMA Network Open, 9(1), e2553538. Key Points Question What are the Medicaid patient retention rates in opioid treatment programs (OTPs) in the...

Source: Howell BA, Kim J, Thornhill TA, et al. Travel Time to Methadone Treatment Via Personal Vehicle vs Public Transit. JAMA Netw Open. 2026;9(2):e2557361. doi:10.1001/jamanetworkopen.2025.57361 Key Points Question How does transportation access to methadone treatment for opioid use disorder via...

Source: Hunt, T., Oser, C., Friedmann, P. et al. Overdose education and naloxone distribution in jails: Examining the impact of the Communities That HEAL intervention in 4 states. Health Justice 13, 47 (2025). https://doi.org/10.1186/s40352-025-00353-5 Abstract Background Opioid-related overdose is...

Source: https://54817af5-b764-42ff-a7e2-97d6e4449c1a.usrfiles.com/ugd/54817a_101ab9cc3f014d22bfdc72727ca61062.pdf 1. Parlez-en tôt et souvent 2. Soutenir les activités saines 3. Définir des attentes claires de non-utilisation 4. Pratiquer les compétences de refus 5. Définir des conséquences claires...

Source: Kepner, W., Vest, N., Risner, E. et al. Three trajectories of implementation of medications for opioid use disorder in primary care. Addict Sci Clin Pract 20, 69 (2025). https://doi.org/10.1186/s13722-025-00600-y Abstract Background The opioid epidemic has prompted nationwide efforts to...

Source: Ware, O.D., Lister, J.J., Cooper, S.E. et al. Subtypes and service utilization among opioid use disorder patients at a community health center: findings from a medically underserved urban area of the Northeastern United States. Addict Sci Clin Pract 20, 39 (2025). https://doi.org/10.1186...

Source: https://www.govinfo.gov/content/pkg/FR-2025-01-16/pdf/2025-00425.pdf The U.S. Department of Health and Human Services (HHS) added fentanyl to its drug testing protocol. The revised drug testing panels will go into effect on July 7, 2025.

Source: Gaudreault P, King SG, Huang Y, et al. Frontal White Matter Changes and Craving Recovery in Inpatients With Heroin Use Disorder. JAMA Netw Open. 2024;7(12):e2451678. doi:10.1001/jamanetworkopen.2024.51678 Key Points Question Does white matter microstructure change during medication-assisted...

Source: Qeadan F, McCunn A, Tingey B. The association between glucose-dependent insulinotropic polypeptide and/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: A real-world data analysis. Addiction. 2024...

Source: Thomas, K. H., Dalili, M. N., Cheng, H. Y., Dawson, S., Donnelly, N., Higgins, J. P., & Hickman, M. (2024). Prevalence of problematic pharmaceutical opioid use in patients with chronic non‐cancer pain: A systematic review and meta‐analysis. Addiction. Abstract Background and aims Chronic non...

Source: Lynch, M., Vargas, D., Winger, M. E., Kanter, J., Meyers, J., Schuster, J., & Yealy, D. (2024). A Telemedicine Bridge Clinic Improves Access and Reduces Cost for Opioid Use Disorder Care. Drug and Alcohol Dependence Reports, 100227. Highlights -A Telemedicine Bridge Clinic effectively...

Source: Sofuoglu, M., DeVito, E. E., & Carroll, K. M. (2019). Pharmacological and behavioral treatment of opioid use disorder. Psychiatric Research and Clinical Practice, 1(1), 4-15. Abstract Objective: Opioid use disorder (OUD) in the United States has surged, with an estimated 2.5 million needing...

Source: Carrieri PM, Michel L, Lions C, Cohen J, Vray M, Mora M, et al. (2014) Methadone Induction in Primary Care for Opioid Dependence: A Pragmatic Randomized Trial (ANRS Methaville). PLoS ONE 9(11): e112328. https://doi.org/10.1371/journal.pone.0112328 Abstract Objective Methadone coverage is...